D116 WGU drugs questions with answers

D116 WGU drugs questions with
|| || || || ||




answers ||




Bethanechol - CORRECT ANSWER(S)✔✔✔Prototype || || || ||



muscarinic agonist used for urinary retention.
|| || || || ||




Mechanism of bethanechol - CORRECT || || || || ||



ANSWER(S)✔✔✔Direct muscarinic receptor agonist that || || || || ||



stimulates parasympathetic activity, increasing bladder
|| || || || ||



contraction and GI motility. || || ||




Common side effects of bethanechol - CORRECT
|| || || || || || ||



ANSWER(S)✔✔✔Bradycardia, hypotension, diarrhea, || || ||



salivation, bronchoconstriction. ||




Dosing and route for bethanechol - CORRECT
|| || || || || || ||



ANSWER(S)✔✔✔10-50 mg PO 3-4 times daily on an || || || || || || || ||



empty stomach.
||




Key patient teaching point for bethanechol - CORRECT
|| || || || || || || ||



ANSWER(S)✔✔✔Take on an empty stomach; report || || || || || ||



excessive sweating, salivation, or dizziness.
|| || || ||

, Neostigmine - CORRECT ANSWER(S)✔✔✔Prototype || || || ||



reversible cholinesterase inhibitor for myasthenia gravis.
|| || || || ||




Mechanism of neostigmine - CORRECT || || || || ||



ANSWER(S)✔✔✔Inhibits acetylcholinesterase, || ||



increasing acetylcholine levels at the neuromuscular
|| || || || || ||



junction.


Common side effects of neostigmine - CORRECT
|| || || || || || ||



ANSWER(S)✔✔✔Cholinergic crisis, bradycardia, GI || || || ||



cramps.


Dosing and route for neostigmine - CORRECT
|| || || || || || ||



ANSWER(S)✔✔✔15-375 mg/day PO in divided doses; || || || || || ||



also available IV/IM.
|| ||




Key patient teaching point for neostigmine - CORRECT
|| || || || || || || ||



ANSWER(S)✔✔✔Space doses evenly; watch for drooling, || || || || ||



diarrhea, or worsening weakness.
|| || || ||




Atropine - CORRECT ANSWER(S)✔✔✔Prototype
|| || || ||



muscarinic antagonist. ||